🤔 This week: TSLA Q3 earnings report - is now the right time to buy the EV giant?Explore TSLA Data

Applovin, Boeing Rise Among Monday's Morning Market Cap Stock Movers

EditorFrank DeMatteo
Published 10/21/2024, 10:45 AM

Monday's stock market has experienced a variety of intra-day movements, with significant activity in both the mega-cap and large-cap categories. Stocks such as NVIDIA (NASDAQ:NVDA), Applovin (APP) and Boeing Co (NYSE:BA) have seen notable increases, while Cigna Corp (NYSE:CI) and Diamond Eagle Acquisition Corp (DKNG) have faced declines. Here's an overview of some of the most impactful stock movers, spanning from mega-caps to small caps.

Mega-Cap Movers:

  • NVIDIA (NVDA): +1.9%; sees continued momentum on AI gains

Large-Cap Stock Movers:

  • Applovin (APP); BofA raises price target to $210; +8.24%
  • Boeing Co (BA); Emirates SkyCargo to Expand Fleet, Capacity with Five More Boeing 777 Freighters; +4.14%
  • Kenvue Inc (NYSE:KVUE); Starboard Value Builds Stake In Tylenol-Maker Kenvue - WSJ; +6.56%
  • Ritchie Bros. Auctioneers (NYSE:RBA); +6.18%
  • Marvell (NASDAQ:MRVL) Technology Group Ltd (MRVL); +3.41%
  • Cigna Corp (CI); falls on report it is in talks again to merge with Huana (HUM); -4.16%
  • DraftKings (NASDAQ:DKNG); -4.11%
  • Monolithic Power (NASDAQ:MPWR); -3.52%

Mid-Cap Stock Movers:

  • Oklo (OKLO); sees continued momentum on big tech's nuclear ambitions; +9.24%
  • Construction Partners Inc (NASDAQ:ROAD); CPI announces acquisition of Lone Star Paving for $654 million; +12.22%
  • Ikonics Corp (WULF); +10.4%
  • Alkami Technology (ALKT); +5.94%
  • Ibotta (IBTA); +5.94%
  • Neumora Therapeutics (NMRA); -14.55%
  • VF Corp (NYSE:VFC); JP Morgan adds to negative catalyst watch; -6.76%
  • Avidity Biosciences Inc (RNA); -7.64%

Small-Cap Stock Movers:

  • Nano Nuclear Energy (NNE); sees continued momentum on big tech's nuclear ambitions; +16.09%
  • Viad Corp (NYSE:VVI); Viad to sell GES unit for $535 million, to become Pursuit; +15.29%
  • Ehang Holdings Ltd (NASDAQ:EH); +14.3%
  • Audioeye, Inc (AEYE); +12.05%
  • European Biotech Acquisition (OCS); Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees; +10.66%
  • HPX (AMBI); +7.74%
  • Alpha Teknova (TKNO); -7.0%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.